Global Atherectomy and Thrombectomy Devices Market Size By Type (Rheolytic, Aspiration), By Application (Hospital, Clnic), By Region, And Segment Forecasts, 2023 to 2032

The Global Atherectomy and Thrombectomy Devices Market was valued at USD 1.8 billion in 2023 and is projected to surpass USD 3.2 billion by 2031, registering a CAGR of 7.2% during the forecast period from 2023 to 2031. The increasing prevalence of cardiovascular diseases (CVDs), peripheral artery diseases (PADs), and venous thromboembolism (VTE) is driving the demand for effective atherectomy and thrombectomy procedures. Technological advancements in medical devices, increasing adoption of minimally invasive surgeries, and a growing aging population are further contributing to the market's expansion.

Drivers

Rising Prevalence of Cardiovascular Diseases

With cardiovascular diseases remaining the leading cause of mortality worldwide, the demand for atherectomy and thrombectomy devices is growing. The increasing incidence of atherosclerosis, deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke is propelling market growth.

Advancements in Medical Technology

Continuous improvements in catheter-based thrombectomy devices, laser atherectomy systems, and mechanical thrombectomy devices are enhancing procedural success rates. The introduction of AI-driven imaging technology and robotic-assisted thrombectomy systems further supports market growth.

Growing Preference for Minimally Invasive Surgeries

Minimally invasive procedures offer reduced recovery time, minimal complications, and lower hospital stays compared to traditional surgical interventions. The increasing adoption of catheter-based thrombectomy and atherectomy devices is driving market expansion.

Restraints

High Cost of Procedures and Devices

Advanced atherectomy and thrombectomy devices come with a high price tag, making them less accessible in low-income and developing regions. Reimbursement challenges in certain countries further limit adoption.

Stringent Regulatory Approvals

The stringent approval process for thrombectomy and atherectomy devices by regulatory bodies like the FDA, EMA, and PMDA can delay product launches, impacting market growth.

Opportunity

Expansion in Emerging Markets

Developing regions such as Asia-Pacific and Latin America are witnessing a surge in healthcare infrastructure investments, increasing awareness, and improving reimbursement policies, creating lucrative opportunities for market players.

Integration of AI and Robotics in Thrombectomy Devices

AI-assisted imaging and robotic thrombectomy procedures are revolutionizing the market by improving precision, efficiency, and patient outcomes. Companies investing in robotic intervention technologies will gain a competitive edge.

Market by System Type Insights

Thrombectomy Devices held the largest market share in 2023, attributed to their growing use in stroke management and pulmonary embolism treatments. The Mechanical Thrombectomy Devices segment is expected to witness the fastest growth due to technological innovations enhancing efficacy and procedural success rates.

Market by End-use Insights

Hospitals Segment Dominates

Hospitals accounted for over 60% of the market share in 2023, as they remain the primary treatment centers for cardiovascular conditions and stroke management. The growing installation of hybrid cath labs within hospitals is further supporting market growth.

Ambulatory Surgical Centers (ASCs) on the Rise

The ASC segment is projected to experience the highest CAGR during the forecast period, driven by an increasing preference for outpatient procedures and lower treatment costs compared to hospitals.

Market by Regional Insights

North America Leads, Asia-Pacific Registers Fastest Growth

North America held the largest share of the Global Atherectomy and Thrombectomy Devices Market in 2023, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong reimbursement policies.

Asia-Pacific is expected to witness the highest CAGR due to rising healthcare investments, increasing aging populations, and a surge in medical tourism in countries such as China, India, and Japan.

Competitive Scenario

Key players in the Global Atherectomy and Thrombectomy Devices Market include:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

BD (Becton, Dickinson and Company)

AngioDynamics, Inc.

Terumo Corporation

Penumbra, Inc.

Stryker Corporation

Philips Healthcare

Cardiovascular Systems, Inc.

These companies are actively focusing on new product launches, strategic collaborations, and geographic expansion to strengthen their market position.

Scope of Work – Global Atherectomy and Thrombectomy Devices Market

Key Market Developments

2023: Medtronic launched next-generation mechanical thrombectomy devices with AI-powered imaging integration for stroke management.

2024: Boston Scientific acquired a leading thrombectomy device manufacturer to expand its vascular intervention portfolio.

2025: Philips Healthcare introduced robotic-assisted atherectomy systems, improving procedural precision and patient safety.

FAQs

1. What is the current market size of the Global Atherectomy and Thrombectomy Devices Market?

The market was valued at USD 1.8 billion in 2023 and is projected to grow significantly by 2031.

2. What is the major growth driver of the Global Atherectomy and Thrombectomy Devices Market?

The increasing prevalence of cardiovascular diseases and peripheral artery diseases, along with technological advancements in medical devices, is driving market growth.

3. Which is the largest region during the forecast period in the Global Atherectomy and Thrombectomy Devices Market?

North America held the largest market share in 2023 due to high disease prevalence, advanced healthcare infrastructure, and strong reimbursement policies.

4. Which segment accounted for the largest market share in the Global Atherectomy and Thrombectomy Devices Market?

Thrombectomy Devices accounted for the largest market share in 2023, particularly in the stroke management and pulmonary embolism treatment segments.

5. Who are the key market players in the Global Atherectomy and Thrombectomy Devices Market?

Key players include Medtronic, Boston Scientific, Abbott, BD, AngioDynamics, Terumo, Penumbra, Stryker, Philips Healthcare, and Cardiovascular Systems, Inc.

This report provides a comprehensive analysis of the Global Atherectomy and Thrombectomy Devices Market, ensuring an engaging, easy-to-understand, trustworthy, and accurate outlook with the latest market trends and data points. 🚀